Cancer cell societies and tumor progression
- PMID: 8318906
- DOI: 10.1002/stem.5530110306
Cancer cell societies and tumor progression
Abstract
It is now well accepted that cancers are heterogeneous and contain multiple subpopulations of cancer cells that differ in important behavioral properties, such as growth rate, ability to metastasize and sensitivity to treatment. This review describes results using a mouse mammary tumor system to model the effect of heterogeneity on tumor growth and response to chemotherapy. Tumor subpopulations that differ in growth and therapy parameters are mixed together to simulate tumor heterogeneity. The mixtures are studied in a variety of protocols designed to detect interactions between the subpopulations and to determine the mechanisms of these interactions. The central conclusion of this work is that tumor subpopulations do not behave independently of each other but rather form a society of cells in which they influence each other's growth and treatment response. The mechanisms by which they do so depend on the unique characteristics of the interacting subpopulations, on the behavior being affected and on the circumstances of their interaction. These observations suggest that the maintenance of tumor heterogeneity is a consequence of the cancer cell society and that cancer behavior and progression depend on interactions among all the members of that society, not just on its most deviant variants.
Similar articles
-
Rates of development of methotrexate resistance in heterogeneous mouse mammary tumor cell cultures.J Exp Ther Oncol. 1996 Jan;1(1):30-8. J Exp Ther Oncol. 1996. PMID: 9414386
-
Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.Clin Cancer Res. 2006 Mar 1;12(5):1479-86. doi: 10.1158/1078-0432.CCR-05-1519. Clin Cancer Res. 2006. PMID: 16533771
-
Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression.Cancer Res. 2006 Apr 1;66(7):3495-503. doi: 10.1158/0008-5472.CAN-04-2372. Cancer Res. 2006. PMID: 16585173
-
Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.Clin Cancer Res. 2003 Oct 1;9(12):4619-26. Clin Cancer Res. 2003. PMID: 14555538
-
Cell-to-cell interaction in regulating diversity of neoplasms.Semin Cancer Biol. 1991 Apr;2(2):97-103. Semin Cancer Biol. 1991. PMID: 1912523 Review.
Cited by
-
Defining the Hallmarks of Metastasis.Cancer Res. 2019 Jun 15;79(12):3011-3027. doi: 10.1158/0008-5472.CAN-19-0458. Epub 2019 May 3. Cancer Res. 2019. PMID: 31053634 Free PMC article. Review.
-
Understanding aneuploidy in cancer through the lens of system inheritance, fuzzy inheritance and emergence of new genome systems.Mol Cytogenet. 2018 May 10;11:31. doi: 10.1186/s13039-018-0376-2. eCollection 2018. Mol Cytogenet. 2018. PMID: 29760781 Free PMC article. Review.
-
Subrenal Capsule Assay - SRCA: The Promising Re-Emergence of a Long-Forgotten Method in Preclinical Nuclear Medical Cancer Diagnostics.J Cancer. 2023 Jan 1;14(2):183-192. doi: 10.7150/jca.78599. eCollection 2023. J Cancer. 2023. PMID: 36741259 Free PMC article. Review.
-
The paradox of cooperation among selfish cancer cells.Evol Appl. 2023 Jul 7;16(7):1239-1256. doi: 10.1111/eva.13571. eCollection 2023 Jul. Evol Appl. 2023. PMID: 37492150 Free PMC article. Review.
-
Defective quorum sensing of acute lymphoblastic leukemic cells: evidence of collective behavior of leukemic populations as semi-autonomous aberrant ecosystems.Am J Cancer Res. 2016 Jun 1;6(6):1177-230. eCollection 2016. Am J Cancer Res. 2016. PMID: 27429840 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources